Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
Times Cited: 12
Times Cited: 12
Times Cited
Times Co-cited
Similarity
SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
50
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
41
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report.
Felicity Brown, Tamara McColl. J Emerg Med 2018
Felicity Brown, Tamara McColl. J Emerg Med 2018
41
Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery.
Aaron Lau, Simon Bruce, Erica Wang, Ron Ree, Kevin Rondi, Anthony Chau. Can J Anaesth 2018
Aaron Lau, Simon Bruce, Erica Wang, Ron Ree, Kevin Rondi, Anthony Chau. Can J Anaesth 2018
41
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
41
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
41
The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
Nellowe Candelario, Jedrzej Wykretowicz. Oxf Med Case Reports 2016
Nellowe Candelario, Jedrzej Wykretowicz. Oxf Med Case Reports 2016
33
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
33
SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications.
Emily J Meyer, Genevieve Gabb, David Jesudason. Diabetes Care 2018
Emily J Meyer, Genevieve Gabb, David Jesudason. Diabetes Care 2018
33
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
33
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
33
Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
Kushani Gajjar, Pooja Luthra. Cureus 2019
Kushani Gajjar, Pooja Luthra. Cureus 2019
36
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
57
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
33
Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.
Pablo Lucero, Sebastián Chapela. Case Rep Crit Care 2018
Pablo Lucero, Sebastián Chapela. Case Rep Crit Care 2018
33
Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
33
Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
50
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
Alexis Diaz-Ramos, Wesley Eilbert, Diego Marquez. Int J Emerg Med 2019
Alexis Diaz-Ramos, Wesley Eilbert, Diego Marquez. Int J Emerg Med 2019
33
Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.
D A Milder, T Y Milder, P C A Kam. Anaesthesia 2018
D A Milder, T Y Milder, P C A Kam. Anaesthesia 2018
25
The effect of anti-emetic doses of dexamethasone on postoperative blood glucose levels in non-diabetic and diabetic patients: a prospective randomised controlled study.
M Tien, T J Gan, I Dhakal, W D White, A J Olufolabi, R Fink, B M Mishriky, H J Lacassie, A S Habib. Anaesthesia 2016
M Tien, T J Gan, I Dhakal, W D White, A J Olufolabi, R Fink, B M Mishriky, H J Lacassie, A S Habib. Anaesthesia 2016
25
SGLT inhibition and euglycaemic diabetic ketoacidosis.
Julia Hine, Heather Paterson, Esha Abrol, David Russell-Jones, Roselle Herring. Lancet Diabetes Endocrinol 2015
Julia Hine, Heather Paterson, Esha Abrol, David Russell-Jones, Roselle Herring. Lancet Diabetes Endocrinol 2015
25
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
25
When Guidelines Fail: Euglycemic Diabetic Ketoacidosis After Bariatric Surgery in a Patient Taking a Sodium-Glucose Cotransporter-2 Inhibitor: A Case Report.
Sophia Lane, David Paskar, Shatha Hamed, Alberto Goffi. A A Pract 2018
Sophia Lane, David Paskar, Shatha Hamed, Alberto Goffi. A A Pract 2018
30
Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis.
Stephanie Dizon, Erin J Keely, Janine Malcolm, Amel Arnaout. Can J Diabetes 2017
Stephanie Dizon, Erin J Keely, Janine Malcolm, Amel Arnaout. Can J Diabetes 2017
25
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
25
Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
Ryan B Dull, Mikayla L Spangler, Emily L Knezevich, Britney M Lau. J Pharm Pract 2019
Ryan B Dull, Mikayla L Spangler, Emily L Knezevich, Britney M Lau. J Pharm Pract 2019
60
SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
25
Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
Yu-Mou Chou, Chen-June Seak, Zhong Ning Leonard Goh, Joanna Chen-Yeen Seak, Chen-Ken Seak, Chih-Chuan Lin. Medicine (Baltimore) 2018
Yu-Mou Chou, Chen-June Seak, Zhong Ning Leonard Goh, Joanna Chen-Yeen Seak, Chen-Ken Seak, Chih-Chuan Lin. Medicine (Baltimore) 2018
25
Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.
Shreya Pujara, Adriana Ioachimescu. J Investig Med High Impact Case Rep 2017
Shreya Pujara, Adriana Ioachimescu. J Investig Med High Impact Case Rep 2017
25
Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Presenting with Acute Pancreatitis.
Karun Badwal, Tooba Tariq, Diane Peirce. Case Rep Endocrinol 2018
Karun Badwal, Tooba Tariq, Diane Peirce. Case Rep Endocrinol 2018
30
Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
25
Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
33
Sodium-glucose cotransporter-2 inhibitors induced eu-glycemic diabetic ketoacidosis: The first report in a type 2 diabetic (T2D) Taiwanese and literature review of possible pathophysiology and contributing factors.
Yi-Hsin Lin. J Formos Med Assoc 2018
Yi-Hsin Lin. J Formos Med Assoc 2018
75
Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
Fernand Bteich, Ghassan Daher, Aniruddh Kapoor, Edward Charbek, Ghassan Kamel. Cureus 2019
Fernand Bteich, Ghassan Daher, Aniruddh Kapoor, Edward Charbek, Ghassan Kamel. Cureus 2019
75
Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and "Sweet Pee Encephalopathy" in Perioperative Hospital Management.
Christopher Mackintosh, Arti Tewari, Jason Siegel, R Doris Wang, William Freeman. Neurohospitalist 2020
Christopher Mackintosh, Arti Tewari, Jason Siegel, R Doris Wang, William Freeman. Neurohospitalist 2020
60
Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report.
Matthew Earle, Brian Ault, Caitlin Bonney. Clin Pract Cases Emerg Med 2020
Matthew Earle, Brian Ault, Caitlin Bonney. Clin Pract Cases Emerg Med 2020
42
Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
Manoj R Somagutta, Kuchalambal Agadi, Namrata Hange, Molly S Jain, Erkan Batti, Bernard O Emuze, Elizabeth O Amos-Arowoshegbe, Sorin Popescu, Saad Hanan, Varadha Retna Kumar,[...]. Cureus 2021
Manoj R Somagutta, Kuchalambal Agadi, Namrata Hange, Molly S Jain, Erkan Batti, Bernard O Emuze, Elizabeth O Amos-Arowoshegbe, Sorin Popescu, Saad Hanan, Varadha Retna Kumar,[...]. Cureus 2021
42
Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin.
Christoffel van Niekerk, James Wallace, Mark Takata, Roger Yu. BMJ Case Rep 2018
Christoffel van Niekerk, James Wallace, Mark Takata, Roger Yu. BMJ Case Rep 2018
40
Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature.
B Chacko, M Whitley, U Beckmann, K Murray, M Rowley. Anaesth Intensive Care 2018
B Chacko, M Whitley, U Beckmann, K Murray, M Rowley. Anaesth Intensive Care 2018
16
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
16
Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
16
Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
A Pfützner, D Klonoff, L Heinemann, N Ejskjaer, J Pickup. Endocrine 2017
A Pfützner, D Klonoff, L Heinemann, N Ejskjaer, J Pickup. Endocrine 2017
16
Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.
Meera Kotagal, Rebecca G Symons, Irl B Hirsch, Guillermo E Umpierrez, E Patchen Dellinger, Ellen T Farrokhi, David R Flum. Ann Surg 2015
Meera Kotagal, Rebecca G Symons, Irl B Hirsch, Guillermo E Umpierrez, E Patchen Dellinger, Ellen T Farrokhi, David R Flum. Ann Surg 2015
16
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.
Guillermo Umpierrez, Saumeth Cardona, Francisco Pasquel, Sol Jacobs, Limin Peng, Michael Unigwe, Christopher A Newton, Dawn Smiley-Byrd, Priyathama Vellanki, Michael Halkos,[...]. Diabetes Care 2015
Guillermo Umpierrez, Saumeth Cardona, Francisco Pasquel, Sol Jacobs, Limin Peng, Michael Unigwe, Christopher A Newton, Dawn Smiley-Byrd, Priyathama Vellanki, Michael Halkos,[...]. Diabetes Care 2015
16
SAFETY AND EFFICACY OF A PERI-OPERATIVE PROTOCOL FOR PATIENTS WITH DIABETES TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WHO ARE ADMITTED FOR SAME-DAY SURGERY.
Sandra I Sobel, Marilyn Augustine, Amy C Donihi, Jodie Reider, Patrick Forte, Mary Korytkowski. Endocr Pract 2015
Sandra I Sobel, Marilyn Augustine, Amy C Donihi, Jodie Reider, Patrick Forte, Mary Korytkowski. Endocr Pract 2015
16
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.
Guillermo E Umpierrez, David C Klonoff. Diabetes Care 2018
Guillermo E Umpierrez, David C Klonoff. Diabetes Care 2018
16
Poor glycemic control is a strong predictor of postoperative morbidity and mortality in patients undergoing vascular surgery.
Chandler A Long, Zachary B Fang, Frances Y Hu, Shipra Arya, Luke P Brewster, Elizabeth Duggan, Yazan Duwayri. J Vasc Surg 2019
Chandler A Long, Zachary B Fang, Frances Y Hu, Shipra Arya, Luke P Brewster, Elizabeth Duggan, Yazan Duwayri. J Vasc Surg 2019
16
Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study.
Guillermo E Umpierrez, Roma Gianchandani, Dawn Smiley, Sol Jacobs, David H Wesorick, Christopher Newton, Farnoosh Farrokhi, Limin Peng, David Reyes, Sangeeta Lathkar-Pradhan,[...]. Diabetes Care 2013
Guillermo E Umpierrez, Roma Gianchandani, Dawn Smiley, Sol Jacobs, David H Wesorick, Christopher Newton, Farnoosh Farrokhi, Limin Peng, David Reyes, Sangeeta Lathkar-Pradhan,[...]. Diabetes Care 2013
16
Clinical Effectiveness of Intravenous Exenatide Infusion in Perioperative Glycemic Control after Coronary Artery Bypass Graft Surgery: A Phase II/III Randomized Trial.
Guillaume Besch, Andrea Perrotti, Frederic Mauny, Marc Puyraveau, Maude Baltres, Guillaume Flicoteaux, Lucie Salomon du Mont, Benoit Barrucand, Emmanuel Samain, Sidney Chocron,[...]. Anesthesiology 2017
Guillaume Besch, Andrea Perrotti, Frederic Mauny, Marc Puyraveau, Maude Baltres, Guillaume Flicoteaux, Lucie Salomon du Mont, Benoit Barrucand, Emmanuel Samain, Sidney Chocron,[...]. Anesthesiology 2017
16
Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries.
Willem van den Boom, Rebecca A Schroeder, Michael W Manning, Tracy L Setji, Gic-Owens Fiestan, David B Dunson. Diabetes Care 2018
Willem van den Boom, Rebecca A Schroeder, Michael W Manning, Tracy L Setji, Gic-Owens Fiestan, David B Dunson. Diabetes Care 2018
16
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.